4.8 Article

A comprehensive phenotypic CRISPR-Cas9 screen of the ubiquitin pathway uncovers roles of ubiquitin ligases in mitosis

Journal

MOLECULAR CELL
Volume 81, Issue 6, Pages -

Publisher

CELL PRESS
DOI: 10.1016/j.molcel.2021.01.014

Keywords

-

Funding

  1. NIH [R35 GM118104]
  2. UCSF RAP Program
  3. UCSF Program for Breakthrough Biomedical Research (Sandler Foundation)
  4. National Cancer Institute cancer center support grant [P30CA082103]
  5. UCSF CAT
  6. UCSF Nikon Imaging Center

Ask authors/readers for more resources

By conducting chemical-genetic CRISPR-Cas9 screens, we identified interactions between certain E3s/DUBs genes and compounds, which clustered functionally. Some genes interacted with multiple compounds, while others interacted primarily with a single compound or related compounds.
The human ubiquitin proteasome system, composed of over 700 ubiquitin ligases (E3s) and deubiquitinases (DUBs), has been difficult to characterize systematically and phenotypically. We performed chemical-genetic CRISPR-Cas9 screens to identify E3s/DUBs whose loss renders cells sensitive or resistant to 41 compounds targeting a broad range of biological processes, including cell cycle progression, genome stability, metabolism, and vesicular transport. Genes and compounds clustered functionally, with inhibitors of related pathways interacting similarly with E3s/DUBs. Some genes, such as FBXW7, showed interactions with many of the compounds. Others, such as RNF25 and FBXO42, showed interactions primarily with a single compound (methyl methanesulfonate for RNF25) or a set of related compounds (the mitotic cluster for FBXO42). Mutation of several E3s with sensitivity to mitotic inhibitors led to increased aberrant mitoses, suggesting a role for these genes in cell cycle regulation. Our comprehensive CRISPR-Cas9 screen uncovered 466 gene-compound interactions covering 25% of the interrogated E3s/DUBs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available